Jogesh Mukherjee - Publications

Affiliations: 
Psychiatry and Human Behavior University of California, Irvine, Irvine, CA 
Area:
Radioligand development, Positron Emission Tomography,

98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Baranwal A, Mirbolooki MR, Mukherjee J. Initial Assessment of β3-Adrenoceptor-Activated Brown Adipose Tissue in Streptozotocin-Induced Type 1 Diabetes Rodent Model Using [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Imaging. 14: 22-33. PMID 26637263 DOI: 10.2310/7290.2015.00028  0.4
2015 Mukherjee J, Bajwa AK, Wooten DW, Hillmer AT, Pan ML, Pandey SK, Saigal N, Christian BT. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species- rodents, nonhuman primates, and humans¶. The Journal of Comparative Neurology. PMID 26509362 DOI: 10.1002/cne.23919  0.4
2015 Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML. Dopamine D3 receptor binding of (18) F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. Synapse (New York, N.Y.). 69: 577-91. PMID 26422464 DOI: 10.1002/syn.21867  0.4
2015 Baranwal A, Mukherjee J. (18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents. Bioorganic & Medicinal Chemistry Letters. 25: 2902-6. PMID 26048782 DOI: 10.1016/j.bmcl.2015.05.053  0.4
2015 Schade KN, Baranwal A, Liang C, Mirbolooki MR, Mukherjee J. Preliminary evaluation of β3-adrenoceptor agonist-induced (18)F-FDG metabolic activity of brown adipose tissue in obese Zucker rat. Nuclear Medicine and Biology. 42: 691-4. PMID 25934347 DOI: 10.1016/j.nucmedbio.2015.04.003  0.4
2015 Thio JP, Liang C, Bajwa AK, Wooten DW, Christian BT, Mukherjee J. Synthesis and Evaluation of Mefway Analogs as Ligands for Serotonin 5HT1A Receptors. Medicinal Chemistry Research : An International Journal For Rapid Communications On Design and Mechanisms of Action of Biologically Active Agents. 24: 1480-1486. PMID 25750500 DOI: 10.1007/s00044-014-1238-z  0.4
2015 Mirbolooki MR, Schade KN, Constantinescu CC, Pan ML, Mukherjee J. Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonist. Synapse (New York, N.Y.). 69: 96-8. PMID 25347981 DOI: 10.1002/syn.21789  0.4
2014 Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1973-9. PMID 25453045 DOI: 10.2967/jnumed.114.145151  0.4
2014 Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride. Nuclear Medicine and Biology. 41: 841-7. PMID 25199843 DOI: 10.1016/j.nucmedbio.2014.08.002  0.4
2014 Wooten DW, Hillmer AT, Murali D, Barnhart TE, Thio JP, Bajwa AK, Bonab AA, Normandin MD, Schneider ML, Mukherjee J, Christian BT. Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway. American Journal of Nuclear Medicine and Molecular Imaging. 4: 483-9. PMID 25143866  0.4
2014 Tang W, Kuruvilla SA, Galitovskiy V, Pan ML, Grando SA, Mukherjee J. Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model. American Journal of Nuclear Medicine and Molecular Imaging. 4: 324-32. PMID 24982818  0.4
2014 Garcia A, Venugopal A, Pan ML, Mukherjee J. Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography. Diabetes Technology & Therapeutics. 16: 640-3. PMID 24828096 DOI: 10.1089/dia.2014.0041  0.4
2014 Pandey SK, Kaur J, Easwaramoorthy B, Shah A, Coleman R, Mukherjee J. Multimodality imaging probe for positron emission tomography and fluorescence imaging studies. Molecular Imaging. 13: 1-7. PMID 24824856 DOI: 10.2310/7290.2014.00005  0.4
2014 Pandey S, Venugopal A, Kant R, Coleman R, Mukherjee J. ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors. Nuclear Medicine and Biology. 41: 426-31. PMID 24602412 DOI: 10.1016/j.nucmedbio.2014.01.011  0.4
2014 Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, et al. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nature Medicine. 20: 215-9. PMID 24412923 DOI: 10.1038/nm.3437  0.4
2014 Baranwal A, Patel HH, Mukherjee J. 18F-Fluorodeoxyglycosylamines: Maillard reaction of 18F-fluorodeoxyglucose with biological amines. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 86-91. PMID 24327460 DOI: 10.1002/jlcr.3168  0.4
2014 Mirbolooki MR, Upadhyay SK, Constantinescu CC, Pan ML, Mukherjee J. Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice. Nuclear Medicine and Biology. 41: 10-6. PMID 24090673 DOI: 10.1016/j.nucmedbio.2013.08.009  0.4
2014 Potkin SG, Keator DB, Kesler-West ML, Nguyen DD, van Erp TG, Mukherjee J, Shah N, Preda A. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder. Cns Spectrums. 19: 176-81. PMID 24073841 DOI: 10.1017/S109285291300059X  0.4
2013 Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Schneider ML, Mukherjee J, Christian BT. Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1806-14. PMID 23942367 DOI: 10.1038/jcbfm.2013.136  0.4
2013 Hillmer AT, Wooten DW, Farhoud M, Higgins AT, Lao PJ, Barnhart TE, Mukherjee J, Christian BT. PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding. Synapse (New York, N.Y.). 67: 882-6. PMID 23913347 DOI: 10.1002/syn.21698  0.4
2013 Upadhyay SK, Eckel-Mahan KL, Mirbolooki MR, Tjong I, Griffey SM, Schmunk G, Koehne A, Halbout B, Iadonato S, Pedersen B, Borrelli E, Wang PH, Mukherjee J, Sassone-Corsi P, Chandy KG. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America. 110: E2239-48. PMID 23729813 DOI: 10.1073/pnas.1221206110  0.4
2013 Pithia N, Gulati N, Pandey S, Coleman R, Kant R, Mukherjee J. Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging. Nuclear Medicine and Biology. 40: 697-704. PMID 23562464 DOI: 10.1016/j.nucmedbio.2013.02.011  0.4
2013 Wooten DW, Hillmer AT, Moirano JM, Tudorascu DL, Ahlers EO, Slesarev MS, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. Neuroimage. 77: 125-32. PMID 23537936 DOI: 10.1016/j.neuroimage.2013.03.027  0.4
2013 Saigal N, Bajwa AK, Faheem SS, Coleman RA, Pandey SK, Constantinescu CC, Fong V, Mukherjee J. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET. Synapse (New York, N.Y.). 67: 596-608. PMID 23504990 DOI: 10.1002/syn.21665  0.4
2013 Hillmer AT, Wooten DW, Farhoud M, Barnhart TE, Mukherjee J, Christian BT. The effects of lobeline on α4β2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats. Journal of Neuroscience Methods. 214: 163-9. PMID 23370310 DOI: 10.1016/j.jneumeth.2013.01.018  0.4
2013 Constantinescu CC, Garcia A, Mirbolooki MR, Pan ML, Mukherjee J. Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice. Nuclear Medicine and Biology. 40: 289-94. PMID 23265670 DOI: 10.1016/j.nucmedbio.2012.11.004  0.4
2013 Nalbandian A, Llewellyn KJ, Badadani M, Yin HZ, Nguyen C, Katheria V, Watts G, Mukherjee J, Vesa J, Caiozzo V, Mozaffar T, Weiss JH, Kimonis VE. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse. Muscle & Nerve. 47: 260-70. PMID 23169451 DOI: 10.1002/mus.23522  0.4
2013 Pichika R, Kuruvilla SA, Patel N, Vu K, Sinha S, Easwaramoorthy B, Narayanan TK, Shi B, Christian B, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET. Nuclear Medicine and Biology. 40: 117-25. PMID 23141552 DOI: 10.1016/j.nucmedbio.2012.09.009  0.4
2013 Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity. Synapse (New York, N.Y.). 67: 79-93. PMID 23080264 DOI: 10.1002/syn.21617  0.4
2013 Constantinescu CC, Sevrioukov E, Garcia A, Pan ML, Mukherjee J. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 222-9. PMID 22833323 DOI: 10.1007/s11307-012-0582-y  0.4
2012 Pandey SK, Pan S, Kant R, Kuruvilla SA, Pan ML, Mukherjee J. Synthesis and evaluation of 3-¹²³I-iodo-5-[2-(S)-3-pyrrolinylmethoxy]-pyridine (niodene) as a potential nicotinic α4β2 receptor imaging agent. Bioorganic & Medicinal Chemistry Letters. 22: 7610-4. PMID 23116890 DOI: 10.1016/j.bmcl.2012.10.012  0.4
2012 Nalbandian A, Llewellyn KJ, Kitazawa M, Yin HZ, Badadani M, Khanlou N, Edwards R, Nguyen C, Mukherjee J, Mozaffar T, Watts G, Weiss J, Kimonis VE. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology. Plos One. 7: e46308. PMID 23029473 DOI: 10.1371/journal.pone.0046308  0.4
2012 Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Murali D, Schneider ML, Mukherjee J, Christian BT. PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1471-80. PMID 22851633 DOI: 10.2967/jnumed.112.103846  0.4
2012 Wooten DW, Hillmer AT, Moirano JM, Ahlers EO, Slesarev M, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1546-58. PMID 22472611 DOI: 10.1038/jcbfm.2012.43  0.4
2012 Bieszczad KM, Kant R, Constantinescu CC, Pandey SK, Kawai HD, Metherate R, Weinberger NM, Mukherjee J. Nicotinic acetylcholine receptors in rat forebrain that bind ¹⁸F-nifene: relating PET imaging, autoradiography, and behavior. Synapse (New York, N.Y.). 66: 418-34. PMID 22213342 DOI: 10.1002/syn.21530  0.4
2012 Reist C, Wu JC, Lilja Y, Mukherjee J, Gripeos D, Constantinescu C, Raggi MA, Mercolini L, Ozdemir V. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? Journal of Clinical Psychopharmacology. 32: 110-3. PMID 22198458 DOI: 10.1097/JCP.0b013e3182408fc8  0.4
2012 Reist C, Mukherjee J, Wu JC. Modulating blood-brain barrier permeability and treatment-resistant psychiatric illness: Is pituitary neuroimaging a new frontier? Current Pharmacogenomics and Personalized Medicine. 10: 182-184. DOI: 10.2174/187569212802509979  0.4
2011 Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation. Ejnmmi Research. 1: 30. PMID 22214183 DOI: 10.1186/2191-219X-1-30  0.4
2011 Kant R, Constantinescu CC, Parekh P, Pandey SK, Pan ML, Easwaramoorthy B, Mukherjee J. Evaluation of F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging. Ejnmmi Research. 1. PMID 22039577 DOI: 10.1186/2191-219X-1-6  0.4
2011 Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. Journal of Molecular Neuroscience : Mn. 45: 522-31. PMID 21892620 DOI: 10.1007/s12031-011-9627-y  0.4
2011 Pichika R, Easwaramoorthy B, Christian BT, Shi B, Narayanan TK, Collins D, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine). Nuclear Medicine and Biology. 38: 1183-92. PMID 21831652 DOI: 10.1016/j.nucmedbio.2011.05.005  0.4
2011 Wooten D, Hillmer A, Murali D, Barnhart T, Schneider ML, Mukherjee J, Christian BT. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nuclear Medicine and Biology. 38: 925-32. PMID 21741252 DOI: 10.1016/j.nucmedbio.2011.04.001  0.4
2011 Garcia A, Mirbolooki MR, Constantinescu C, Pan ML, Sevrioukov E, Milne N, Wang PH, Lakey J, Chandy KG, Mukherjee J. 18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1125-32. PMID 21680697 DOI: 10.2967/jnumed.111.088583  0.4
2011 Hillmer AT, Wooten DW, Moirano JM, Slesarev M, Barnhart TE, Engle JW, Nickles RJ, Murali D, Schneider ML, Mukherjee J, Christian BT. Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse (New York, N.Y.). 65: 1309-18. PMID 21674627 DOI: 10.1002/syn.20965  0.4
2011 Wooten DW, Moraino JD, Hillmer AT, Engle JW, Dejesus OJ, Murali D, Barnhart TE, Nickles RJ, Davidson RJ, Schneider ML, Mukherjee J, Christian BT. In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse (New York, N.Y.). 65: 592-600. PMID 21484878 DOI: 10.1002/syn.20878  0.4
2011 Constantinescu CC, Coleman RA, Pan ML, Mukherjee J. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride. Synapse (New York, N.Y.). 65: 778-87. PMID 21218455 DOI: 10.1002/syn.20904  0.4
2010 Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, Caiozzo V, Warman M, Kimonis VE. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. Plos One. 5. PMID 20957154 DOI: 10.1371/journal.pone.0013183  0.4
2010 Nguyen VL, Pichika R, Bhakta PH, Kant R, Mukherjee J. (R)-N-Methyl-3-(3'-[F]fluoropropyl)phenoxy)-3-phenylpropanamine (F-MFP3) as a potential PET imaging agent for norepinephrine transporter. Journal of Labelled Compounds & Radiopharmaceuticals. 53: 172-177. PMID 20495670 DOI: 10.1002/jlcr.1744  0.4
2010 Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 994-1007. PMID 20040928 DOI: 10.1038/jcbfm.2009.270  0.4
2009 Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14734-40. PMID 19940168 DOI: 10.1523/JNEUROSCI.3765-09.2009  0.4
2009 Constantinescu CC, Mukherjee J. Performance evaluation of an Inveon PET preclinical scanner. Physics in Medicine and Biology. 54: 2885-99. PMID 19384008 DOI: 10.1088/0031-9155/54/9/020  0.4
2008 Airaksinen AJ, Nag S, Finnema SJ, Mukherjee J, Chattopadhyay S, Gulyás B, Farde L, Halldin C. [11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors. Bioorganic & Medicinal Chemistry. 16: 6467-73. PMID 18534857 DOI: 10.1016/j.bmc.2008.05.039  0.4
2008 Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 10: 1-18. PMID 17957408 DOI: 10.1007/s11307-007-0115-2  0.4
2007 Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse (New York, N.Y.). 61: 29-36. PMID 17068780 DOI: 10.1002/syn.20338  0.4
2007 Mukherjee J, Head E, Pichika R, Easwaramoorthy B, Collins D, Chen I, Wang CS, Saigal N, Trinidad P, Kim K, Nguyen VL. Radiotracers for a multi-target approach to the diagnosis of Alzheimer's disease Journal of Labelled Compounds and Radiopharmaceuticals. 50: 375-379. DOI: 10.1002/jlcr.1266  0.4
2006 Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 1697-706. PMID 17015907  0.4
2006 Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophrenia Research. 85: 232-44. PMID 16713185 DOI: 10.1016/j.schres.2006.03.042  0.4
2006 Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nuclear Medicine and Biology. 33: 295-304. PMID 16631077 DOI: 10.1016/j.nucmedbio.2005.12.017  0.4
2006 Shikhaliev PM, Xu T, Ducote JL, Easwaramoorthy B, Mukherjee J, Molloi S. Positron autoradiography for intravascular imaging: feasibility evaluation. Physics in Medicine and Biology. 51: 963-79. PMID 16467590 DOI: 10.1088/0031-9155/51/4/014  0.4
2005 Schneider ML, Moore CF, Barnhart TE, Larson JA, DeJesus OT, Mukherjee J, Nickles RJ, Converse AK, Roberts AD, Kraemer GW. Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 29: 1685-97. PMID 16205369 DOI: 10.1097/01.alc.0000179409.80370.25  0.4
2005 Padma MV, Adineh M, Pugar K, Mukherjee J, Satter M, Shi B, Dunigan K, Bidwell K, Ezzeddine B, Mantil J. Functional imaging of a large demyelinating lesion. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 12: 176-8. PMID 15749424 DOI: 10.1016/j.jocn.2004.02.024  0.4
2005 Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Research. 1032: 77-84. PMID 15680944 DOI: 10.1016/j.brainres.2004.11.005  0.4
2005 Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 130-40. PMID 15632043  0.4
2004 Padma MV, Simkins R, White P, Satter M, Christian BT, Dunigan K, Lee C, Jacobs M, Mukherjee J, Mantil JC. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurology India. 52: 457-62. PMID 15626833  0.4
2004 Mukherjee J, Narayanan TK, Christian BT, Shi B, Yang ZY. Binding characteristics of high-affinity dopamine D2/D3 receptor agonists, 11C-PPHT and 11C-ZYY-339 in rodents and imaging in non-human primates by PET. Synapse (New York, N.Y.). 54: 83-91. PMID 15352133 DOI: 10.1002/syn.20068  0.4
2004 Christian BT, Narayanan T, Shi B, Morris ED, Mantil J, Mukherjee J. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 309-22. PMID 15091112 DOI: 10.1097/01.WCB.0000105020.93708.DD  0.4
2004 Shi B, Narayanan TK, Christian BT, Chattopadhyay S, Mukherjee J. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5′-18F- fluoropentyl)aminotetralin (18F-5-OH-FPPAT) in rodents and nonhuman primates Nuclear Medicine and Biology. 31: 303-311. PMID 15028242 DOI: 10.1016/j.nucmedbio.2003.10.004  0.4
2004 Roberts AD, Moore CF, DeJesus OT, Barnhart TE, Larson JA, Mukherjee J, Nickles RJ, Schueller MJ, Shelton SE, Schneider ML. Prenatal stress, moderate fetal alcohol, and dopamine system function in rhesus monkeys. Neurotoxicology and Teratology. 26: 169-78. PMID 15019951 DOI: 10.1016/j.ntt.2003.12.003  0.4
2004 Mukherjee J, Shi B, Christian BT, Chattopadhyay S, Narayanan TK. 11C-Fallypride: Radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain Bioorganic and Medicinal Chemistry. 12: 95-102. PMID 14697774 DOI: 10.1016/j.bmc.2003.10.020  0.4
2004 Mukherjee J, Shi B, Narayanan TK, Christian BT, Zhi-Ying Y. Radiopharmaceuticals for Imaging the Brain Emission Tomography: the Fundamentals of Pet and Spect. 89-101. DOI: 10.1016/B978-012744482-6.50008-9  0.4
2002 Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J. Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors Synapse. 46: 170-188. PMID 12325044 DOI: 10.1002/syn.10128  0.4
2002 Narayanan TK, Said S, Mukherjee J, Christian B, Satter M, Dunigan K, Shi B, Jacobs M, Bernstein T, Padma M, Mantil J. A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma Molecular Imaging and Biology. 4: 147-156. DOI: 10.1016/S1536-1632(01)00010-5  0.4
2001 Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride Neuropsychopharmacology. 25: 476-488. PMID 11557161 DOI: 10.1016/S0893-133X(01)00251-2  0.4
2001 Kapp OH, Siemion J, Kuo J, Johnson BA, Shankaran V, Reba RC, Mukherjee J. Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: A molecular modeling study Journal of Molecular Modeling. 7: 6-18. DOI: 10.1007/S008940100002  0.4
2000 Christian BT, Narayanan TK, Shi B, Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [18F]fallypride in nonhuman primates Synapse. 38: 71-79. PMID 10941142 DOI: 10.1002/1098-2396(200010)38:1<71::AID-SYN8>3.0.CO;2-2  0.4
2000 Mukherjee J, Narayanan TK, Christian BT, Shi B, Dunigan KA, Mantil J. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist 11C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate Synapse. 37: 64-70. PMID 10842352 DOI: 10.1002/(SICI)1098-2396(200007)37:1<64::AID-SYN7>3.0.CO;2-F  0.4
2000 Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J. Measurement of striatal and extrastriatal D-2 receptor occupancy by clozapine and risperidone using [18F]fallypride and PET Neuroimage. 11: S53.  0.4
2000 Mukherjee J, Shi B, Narayanan TK, Christian B, Said S, Mantil J. Development and evaluation of dopamine D-2 receptor agonists for In Vivo imaging using PET Neuroimage. 11: S30.  0.4
1999 Shi B, Narayanan TK, Yang ZY, Christian BT, Mukherjee J. Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors Nuclear Medicine and Biology. 26: 725-735. PMID 10628551 DOI: 10.1016/S0969-8051(99)00051-7  0.4
1999 Mukherjee J, Yang ZY. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A Nuclear Medicine and Biology. 26: 619-625. PMID 10587099 DOI: 10.1016/S0969-8051(99)00027-X  0.4
1999 Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride Nuclear Medicine and Biology. 26: 519-527. PMID 10473190 DOI: 10.1016/S0969-8051(99)00012-8  0.4
1999 Mukherjee J, Yang ZY, Lew R. N-(6-18F-fluorohexyl)-N-methylpropargylamine: A fluorine-18-labeled monoamine oxiduse B inhibitor for potential use in PET studies Nuclear Medicine and Biology. 26: 111-116. PMID 10096510 DOI: 10.1016/S0969-8051(98)00061-4  0.4
1999 Mukherjee J, Yang ZY. Monoamine oxidase A inhibition by fluoxetine: An in vitro and in vivo study Synapse. 31: 285-289. PMID 10051109 DOI: 10.1002/(SICI)1098-2396(19990315)31:4<285::AID-SYN6>3.0.CO;2-5  0.4
1999 Yang ZY, Mukherjee J. N-[(1-cyclopropylmethyl-2-pyrrolidinyl)methyl]-substituted benzamides: Synthesis and dopamine D-2 and D-3 receptor binding affinities Medicinal Chemistry Research. 9: 1-8.  0.4
1999 Shi B, Narayanan TK, Yangs ZY, Mukherjee J. Radiosyntheses and in vitro evaluation of 2(N-alkyl-N-1-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors Journal of Labelled Compounds and Radiopharmaceuticals. 42: S384-S386.  0.4
1998 Mukherjee J, Das MK, Yang ZY, Lew R. Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: An in vitro and in vivo study Nuclear Medicine and Biology. 25: 605-610. PMID 9804041 DOI: 10.1016/S0969-8051(98)00043-2  0.4
1997 Kao CM, Yap JT, Mukherjee J, Wernick MN. Image reconstruction for dynamic PET based on low-order approximation and restoration of the sinogram. Ieee Transactions On Medical Imaging. 16: 738-49. PMID 9533575 DOI: 10.1109/42.650871  0.4
1997 Mukherjee J, Yang ZY. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): An in vitro and in vivo study European Journal of Pharmacology. 337: 111-114. PMID 9389388 DOI: 10.1016/S0014-2999(97)01233-8  0.4
1997 Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, Seiden LS. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse (New York, N.Y.). 27: 1-13. PMID 9268060 DOI: 10.1002/(SICI)1098-2396(199709)27:1<1::AID-SYN1>3.0.CO;2-9  0.4
1997 Pan X, La Riviere PJ, Ye J, Mukherjee J, Chen CT. Efficient sinogram smoothing for dynamic neuroreceptor PET imaging Proceedings of Spie - the International Society For Optical Engineering. 3033: 140-146.  0.4
1996 Yang ZY, Perry B, Mukherjee J. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors Nuclear Medicine and Biology. 23: 793-805. PMID 8940723 DOI: 10.1016/0969-8051(96)00076-5  0.4
1996 Ouyang X, Mukherjee J, Yang ZY. Synthesis, radiosynthesis, and biological evaluation of fluorinated thienylcyclohexyl piperidine derivatives as potential radiotracers for the NMDA receptor-linked calcium ionophore Nuclear Medicine and Biology. 23: 315-324. PMID 8782243 DOI: 10.1016/0969-8051(95)02086-1  0.4
1996 Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M. 18F-desmethoxyfallypride: A fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for pet imaging studies of dopamine D2 receptors Life Sciences. 59: 669-678. PMID 8761017 DOI: 10.1016/0024-3205(96)00348-7  0.4
1995 Mukherjee J, Yang ZY, Das MK, Brown T. Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer Nuclear Medicine and Biology. 22: 283-296. PMID 7627142 DOI: 10.1016/0969-8051(94)00117-3  0.4
1995 Wernick MN, Wang G, Kao CM, Yap JT, Mukherjee J, Cooper M, Chen CT. Image reconstruction method for dynamic PET Ieee Nuclear Science Symposium & Medical Imaging Conference. 3: 1718-1722.  0.4
1994 Chen CT, Aarsvold JN, Block TA, Matthews KL, Mintzer RA, Mukherjee J, Yasillo NJ, River LP, Cooper M, Lee RC. Radionuclide probes for tissue damage. Annals of the New York Academy of Sciences. 720: 181-91. PMID 8010637 DOI: 10.1111/j.1749-6632.1994.tb30446.x  0.4
1994 Mukherjee J, Ouyang XH, Yang ZY. [18F]fluorine labeled TCP-derivatives for the NMDA receptor-linked calcium ionophore Journal of Labelled Compounds and Radiopharmaceuticals. 35: 504-506.  0.4
1994 Yang ZY, Mukherjee J. In vivo evaluation of fluorinated benzazepines as selective, high affinity PET tracers for dopamine D-1 receptors Journal of Labelled Compounds and Radiopharmaceuticals. 35: 427-429.  0.4
Show low-probability matches.